Effective Tyrosinase Inhibition & Thiamidol Formulations for Visible Dark Spot Correction on Face and Body

Date: September 15, 2026

Speakers: Heather Woolery-Lloyd, MD; Julie Harper, MD

Sponsored by: Beiersdorf

Learning Objectives

  • Describe the role of tyrosinase in melanin production and explain why tyrosinase inhibition is a targeted approach to reducing the appearance of visible dark spots
  • Review the clinical data for Thiamidol-based formulations on the management of dark spots
  • Discuss routine selection across face, periorbital, and body formulations, including the importance of daily photoprotection as part of overall dark spot maintenance

Skincare Education Symposium

On-demand education from the SES webinar series for dermatology providers.